Thirty-day readmissions and LOS were significantly lowered for malnourished inpatients by use of an EMR-cued MST, prompt provision of ONS, patient/caregiver education, and sustained nutrition support.
cal costs and 802 million work days in absenteeism in 2025. In the same year 210 million people will have at least 1 chronic disease. Treating the chronic conditions will consume 35 cents out of every dollar spent on healthcare in the following 10 years. The 'optimistic' scenario would result in 51 million fewer diagnoses and 780 billion in total direct medical cost savings by 2025. ConClusions: Costs associated with chronic diseases constitute a significant portion of all healthcare spending. Investing in population health initiatives could effectively reduce the burden 10 years from now.
Background
Despite growth of robotic surgery, published literature lacks assessment of the cost of ownership (CoO) of a da Vinci robot by surgical service line and the associated benefit such data provides.
Methods
Based on real‐world data (RWD) from 14 US hospitals and ≈6000 da Vinci robotic cases, CoO was assessed using all relevant fixed and variable cost components, calculated by surgical service line.
Results
At a representative hospital with an efficient robotic program (n = 424 cases), the weighted average fixed cost per case was $984. Weighted average variable cost per case was $8025 (range: $3325 for Cholecystectomy—multiport, to $16 986 for Rectal Resection). Assessing weighted average by case, main variable cost drivers were non‐da Vinci supplies (49.5%), staff costs (28.6%), and da Vinci supplies (21.9%).
Conclusions
Case mix, annual robotic case volumes, and cut‐to‐close/patient‐in‐room time by surgical service line represent core variables influencing robotic program CoO, which help drive profitable program management.
Objectives
Comparison of retrospective, learning curve benign hysterectomy cost and case time data from Senhance total laparoscopic hysterectomy (TLH) cases with similar da Vinci robot cases and laparoscopic‐assisted vaginal hysterectomy (LAVH) cases.
Methods
Instrument costs, console time, and case time analysis from six surgeons at four U.S. and European hospitals compared with retrospective, sequential da Vinci TLH and standard laparoscopic LAVH cases extracted from the CAVAlytics database.
Results
Senhance Gyn surgeons in their learning curve when compared to da Vinci learning curve Gyn surgeons achieved lower median instrument costs ($559 vs. $1393, respectively, p < 0.001) with comparable console times (91.5 vs. 96 min, p = 0.898); Senhance and LAVH case costs were comparable ($559 vs. $498, p = 0.336).
Conclusion
In benign hysterectomy, the Senhance system may present a lower‐cost approach with equivalent case times compared with similar da Vinci robotic cases.
Background: Robotic surgery is seen by many hospital administrators and surgeons as slower and more expensive than laparoscopic surgery despite the implementation of commonly held robotic best practices. Multiple factors, including surgeon learning curves and program governance, are often overlooked, precluding optimal robotic program performance.Methods: An assessment of several leading robotic surgery publications is presented followed by real-world case studies from two US hospitals: an existing robotic program in a mid-sized, regional hospital system and a small, rural hospital that launched a new program.Results: Improvements in robotic surgery costs/program efficiency were seen at the hospital system vs baseline at 18 months post-implementation; and high-performance robotic efficiency and cost benchmarks were matched or surpassed at the rural hospital at 1 year post-launch.Discussion: When best practices are utilized in robotic programs, surgical case times, costs, and efficiency performance metrics equaling or exceeding laparoscopy can be achieved.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.